Inhibition of autoantigen-induced B-cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL). - Górniak P; Polak A; Rams A; Kupcova K; Głodkowska-Mrówka E; Pilch Z; Miączyńska M; Nowis D; Gołąb J; Davis RE; Havranek O; Juszczyński P (Cell death & disease, 2026)